Cybin (HELP) Interest Expenses (2021 - 2026)
Cybin's (HELP) quarterly Interest Expenses came in at $68.2 million in Q1 2026, up 59.77% YoY from $42.7 million in Q1 2025, and up 2437.81% on a QoQ basis from -$2.9 million in Q2 2025.
Cybin (HELP) Interest Expenses (2021 - 2026) Analysis & Trends
Cybin (HELP) has 4 years of Interest Expenses data on file, last reported at $68.2 million in Q1 2026.
- Quarterly Interest Expenses rose 59.77% year-over-year to $68.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.2 million (up 59.77% YoY) and the FY2026 annual result came in at $68.2 million, up 60.08% from the prior year.
- Interest Expenses improved to $68.2 million in Q1 2026, from -$2.9 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $68.2 million in Q1 2026 to a low of -$2.9 million in Q2 2025.
- A 3-year average of $36.4 million and a median of $40.2 million in 2025 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2025 — Interest Expenses advanced 13.42% — and 2026, when it surged 59.77%.
- Tracing HELP's Interest Expenses over 3 years: stood at $37.6 million in 2024, then tumbled by 107.75% to -$2.9 million in 2025, then soared by 2437.81% to $68.2 million in 2026.
- The last three Interest Expenses figures came in at $68.2 million (Q1 2026), -$2.9 million (Q2 2025), and $42.7 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | 68.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.19 Mn |
| Mar 31, 2026 | 68.19 Mn |
| Jun 30, 2025 | -2.92 Mn |
| Jun 30, 2025 | -2.92 Mn |
| Mar 31, 2025 | 42.68 Mn |
| Mar 31, 2025 | 42.68 Mn |
| Mar 31, 2024 | 37.63 Mn |
| Mar 31, 2024 | 37.63 Mn |
| Mar 31, 2021 | 5.39 Mn |
| Mar 31, 2021 | 5.39 Mn |